Citigroup Inc Clear Point Neuro, Inc. Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Clear Point Neuro, Inc. stock. As of the latest transaction made, Citigroup Inc holds 90,568 shares of CLPT stock, worth $1.06 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

90,568

Previous 10,839 735.58%

Holding current value

$1.06 Million

Previous $58,000 1650.0%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$5.3 - $13.18 $422,563 - $1.05 Million	79,729 Added 735.58%	90,568 $1.02 Million
Q2 2024 Aug 12, 2024	BUY	$5.25 - $6.73 $36,765 - $47,130	7,003 Added 182.56%	10,839 $58,000
Q1 2024 May 10, 2024	BUY	$6.03 - $7.86 $3,033 - $3,953	503 Added 15.09%	3,836 $26,000
Q4 2023 Feb 09, 2024	BUY	$4.46 - $7.07 $14,682 - $23,274	3,292 Added 8029.27%	3,333 $22,000
Q3 2023 Nov 09, 2023	SELL	$5.01 - $7.09 $33,997 - $48,112	-6,786 Reduced 99.4%	41 $0
Q2 2023 Aug 10, 2023	SELL	$6.54 - $10.58 $475,575 - $769,356	-72,718 Reduced 91.42%	6,827 $49,000
Q1 2023 May 11, 2023	BUY	$7.33 - $10.63 $73 - $106	10 Added 0.01%	79,545 $671,000
Q4 2022 Feb 09, 2023	BUY	$7.7 - $11.21 $542,257 - $789,441	70,423 Added 772.86%	79,535 $673,000
Q3 2022 Nov 10, 2022	BUY	$9.82 - $16.49 $73,384 - $123,229	7,473 Added 455.95%	9,112 $94,000
Q2 2022 Aug 10, 2022	SELL	$7.09 - $13.65 $10,599 - $20,406	-1,495 Reduced 47.7%	1,639 $21,000
Q1 2022 May 12, 2022	SELL	$7.8 - $11.6 $13,767 - $20,474	-1,765 Reduced 36.03%	3,134 $33,000
Q4 2021 Feb 10, 2022	BUY	$11.08 - $18.86 $29,118 - $49,564	2,628 Added 115.72%	4,899 $55,000
Q3 2021 Nov 10, 2021	BUY	$16.58 - $22.25 $37,653 - $50,529	2,271 New	2,271 $40,000

Others Institutions Holding CLPT

# of Institutions

Shares Held

6.81M

Call Options Held

84.3K

Put Options Held

56.7K

View Full List

About ClearPoint Neuro, Inc.

Ticker CLPT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,488,300
Market Cap $286M
Description
ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain ...

More about CLPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account